
    
      Patients will be randomly assigned to PRU-guided and non-PRU-guided group. In the non-PRU
      -target group, dual antiplatelet therapy with clopidogrel 75 mg and aspirin 100 mg daily will
      be continued for 6 months after the procedure for patient followed with single antiplatelet
      therapy with clopidogrel 75 mg daily throughout the follow-up period. In the PRU-target
      group, dual antiplatelet therapy will be the same protocol as in the non-PRU-target group for
      patients with PRU <234 seconds. However, for patients in the PRU-target group with PRU â‰¥234
      seconds, rescue medicine will be added to keep PRU<234 seconds.
    
  